Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia

• Váldodahkkit: Geng Li (Dahkki), Ruxue Han (Dahkki), Mingjun Lin (Dahkki), Zehuai Wen (Dahkki), Xiankun Chen (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Chinese medicine (CM) is widely used for treating hyperlipidemias, especially in China. However, the heterogeneity of outcomes measured and reported across trials exacerbates the obstacles of evidence synthesis and effectiveness comparison. In this study, we develop a core outcome set (C...